Vanguard Capital Management Acquires 7.51% Stake in IDEXX Laboratories Inc (IDXX)

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, reporting a significant new position in IDEXX Laboratories Inc (IDXX). As of the event date on March 31, 2026, Vanguard beneficially owns 5,976,472 shares of common stock, representing a 7.51% ownership stake in the company. This filing indicates a substantial increase from a previously reported 0% position. The reporting entity, an investment adviser based in Malvern, PA, holds sole dispositive power over all 5,976,472 shares, while exercising sole voting power over 793,965 shares. The filing includes holdings by various affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. Vanguard certified that these shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. No other single person's interest in these securities exceeds 5% of the total shares outstanding.